- Author:
Hong-Mei YOU
1
;
Ling WANG
1
;
Fang-Tian BU
1
;
Hong-Wu MENG
1
;
Xue-Yin PAN
1
;
Ya-Fei ZHANG
1
;
Ao WANG
1
;
Cheng HUANG
1
;
Jun LI
1
Author Information
- Publication Type:Journal Article
- Keywords: activation; HSCs; liver fibrosis; miRNAs; proliferation; apoptosis; senescence
- From: Chinese Pharmacological Bulletin 2021;37(2):171-175
- CountryChina
- Language:Chinese
- Abstract: Liver fibrosis is one of the main diseases with high morbidity and mortality worldwide. It is the common pathological results of several chronic irritant disease such as viral hepatitis ,alcohol abuse, autoimmune diseases, metabolic diseases and cholestatic liver diseases and will further develop into cirrhosis ,liver failure, portal hypertension and even death. The excessive accumulation of extracellular matrix (ECM) that leads to disorder of liver structure is the main factor in the development of liver fibrosis. MicroRNAs are a class of 2225 nt endogenous noncoding small RNAs. Sufficient studies have shown that the abnormal expression of microRNAs is closely related to the progression of liver fibrosis. In this review, we summarize the regulatory effects of microRNAs discovered in recent years on the activation ,proliferation apoptosis and senescence of HSCs in liver fibrosisand the underlying mechanisms, putting forward the prospect.